[1]
Wu, H-Z.; Xiao, J-Q.; Xiao, S-S.; Cheng, Y. KRAS: A promising therapeutic target for cancer treatment. Curr. Top. Med. Chem., 2019, 19(23), 2081-2097.
[2]
Chen, F.; Alphonse, M.P.; Liu, Y. Liu, Q. Targeting mutant KRAS for anticancer therapy. Curr. Top. Med. Chem., 2019, 19(23), 2098-2113.
[3]
Ye, N.; Xu, Q.; Li, W.; Wang, P.; Zhou, J. Recent advances in developing k-ras plasma membrane localization inhibitors. Curr. Top. Med. Chem., 2019, 19(23), 2114-2127.
[4]
He, H.; Xu, C.; Cheng, Z.; Qian, X.; Zheng, L. Drug combinatorial therapies for the treatment of KRAS mutated lung cancers. Curr. Top. Med. Chem., 2019, 19(23), 2128-2142.
[5]
Shao, Y-T.; Ma, L.; Zhang, T-H.; Xu, T-R.; Ye, Y-C.; Liu, Y. The application of the RNA interference technologies for KRAS: current status, future perspective and associated challenges. Curr. Top. Med. Chem., 2019, 19(23), 2143-2157.
Current Topics in Medicinal Chemistry
Title:Drug Discovery by Targeting Mutant KRAS
Volume: 19 Issue: 23
Author(s): Na Ye
Affiliation:
Export Options
About this article
Cite this article as:
Ye Na , Drug Discovery by Targeting Mutant KRAS, Current Topics in Medicinal Chemistry 2019; 19 (23) . https://dx.doi.org/10.2174/156802661923191113144238
DOI https://dx.doi.org/10.2174/156802661923191113144238 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Biosystems Engineering of Prokaryotes with Tumor-Killing Capacities
Current Pharmaceutical Design Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ?
Current Drug Targets Recent Development of Small Molecule Glutaminase Inhibitors
Current Topics in Medicinal Chemistry Peptide-Based Anticancer Vaccines: Recent Advances and Future Perspectives
Current Medicinal Chemistry Cancer Resistance to Type II Topoisomerase Inhibitors
Current Medicinal Chemistry Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Role of Gut Microbiota in Human Health and Diseases
Current Nutrition & Food Science Novel Anticancer Strategy Aimed at Targeting Shelterin Complexes by the Induction of Structural Changes in Telomeric DNA: Hitting two Birds with one Stone
Current Cancer Drug Targets Targeted Tumor Therapies at a Glance
Current Drug Targets Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options
Current Cancer Drug Targets P38 MAPK Contributes to Resistance and Invasiveness of HER2- Overexpressing Breast Cancer
Current Medicinal Chemistry Nanotechnology as a Promising Strategy for Anticancer Drug Delivery
Current Drug Delivery Current Biomarkers for Lung Cancer
Current Signal Transduction Therapy From Chemical Graphs in Computer-Aided Drug Design to General Markov-Galvez Indices of Drug-Target, Proteome, Drug-Parasitic Disease, Technological, and Social-Legal Networks
Current Computer-Aided Drug Design Yeast as a Model System to Study Trafficking of Small Vesicles Carrying Signal-less Proteins In and Out of the Cell
Current Protein & Peptide Science Harnessing Phage Display for the Discovery of Peptide-Based Drugs and Monoclonal Antibodies
Current Medicinal Chemistry Can We Effectively Degrade Microcystins? - Implications on Human Health
Anti-Cancer Agents in Medicinal Chemistry The Role of the Antiangiogenetic Ramucirumab in the Treatment of Advanced Non Small Cell Lung Cancer
Current Medicinal Chemistry The Anti-Oxidant Properties of Isothiocyanates: A Review
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Close Interplay of Nitro-Oxidative Stress, Advanced Glycation end Products and Inflammation in Inflammatory Bowel Diseases
Current Medicinal Chemistry